Detalhe da pesquisa
1.
Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy.
Cell
; 160(5): 977-989, 2015 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-25723171
2.
An in-tumor genetic screen reveals that the BET bromodomain protein, BRD4, is a potential therapeutic target in ovarian carcinoma.
Proc Natl Acad Sci U S A
; 112(1): 232-7, 2015 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-25535366
3.
Establishment of Patient-Derived Tumor Xenograft Models of Epithelial Ovarian Cancer for Preclinical Evaluation of Novel Therapeutics.
Clin Cancer Res
; 23(5): 1263-1273, 2017 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27573169
4.
Aberrations of p16INK4A, p14ARF and p15INK4B genes in pediatric solid tumors.
Int J Oncol
; 23(4): 1151-7, 2003 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-12963998
5.
Mesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance.
J Clin Invest
; 124(6): 2611-25, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24762435
6.
Profiles of genomic instability in high-grade serous ovarian cancer predict treatment outcome.
Clin Cancer Res
; 18(20): 5806-15, 2012 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22912389
7.
A comprehensive analysis of PAX8 expression in human epithelial tumors.
Am J Surg Pathol
; 35(6): 816-26, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21552115
8.
Overexpression of elafin in ovarian carcinoma is driven by genomic gains and activation of the nuclear factor kappaB pathway and is associated with poor overall survival.
Neoplasia
; 12(2): 161-72, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20126474
9.
An activated ErbB3/NRG1 autocrine loop supports in vivo proliferation in ovarian cancer cells.
Cancer Cell
; 17(3): 298-310, 2010 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-20227043